Back to Journal

SM Journal of Gynecology and Obstetrics

Dual Contraceptive Utilization and Associated Factors among Human Immunodeficiency Virus (HIV) Positive Women Attending Anti Retro Viral Therapy (ART) Clinic in Hossana Hospital, Southern Ethiopia

[ ISSN : 2573-6744 ]

Abstract
Details

Received: 27-Jul-2017

Accepted: 18-Aug-2017

Published: 30-Aug-2017

Markos Selamu Jifar¹, Tilahun Beyene Handiso¹, Temesgen Debero Mare¹, and Shabeza Aliye Ibrahim²*

¹ Department of Public Health (MPH), Health Office, Hossana, Ethiopia; Epidemiology, Institute of Health, Jimma University, Ethiopia
² Department of Statistics, Wachemo University, Ethiopia

Corresponding Author:

Tilahun Beyene Handiso, Markos Selamu Jifar, Department of Epidemiology, Institute of Health, Jimma University, Ethiopia, Tel: +251916356889, +251916696915; Email: tilahunbeyene44@gmail.com, marksena15@gmail.com

Keywords

Dual contraceptive; Human immune deficiency virus; Hossana hospita

Abstract

Background: (Assuming this is the missing first paragraph)
infections, including human immune deficiency virus. Also antiretroviral treatment has contributed a lot in decline of human immune deficiency virus related morbidity and mortality but a little of it is known in our country.

Objectives:
To assess dual contraceptive utilization and associated factors among pre-ART and ART women living with human immune deficiency virus.

Methods:
Facility based cross-sectional study was conducted. Data were collected through interview using structured questionnaires. Participants were selected by using simple random sampling technique from patient registration book. Bivariate and multivariable analysis was performed using logistic regression on SPSS version 20.0. Adjusted odds ratio with 95%CI was used.

Results:
The prevalence of dual contraceptive utilization of women living with human immune deficiency virus in the Hospital was 28.3% (95% CI: 23.8, 33.7) and significantly associated with receiving follow up counseling (AOR: 6.05; 95% CI: 2.46, 14.83), starting ART(AOR: 0.21; CI: 0.07, 0.64), had no child (AOR: 0.19; 95% CI: 0.06, 0.57), supporting to use (AOR: 6.36; 95% CI: 2.49, 16.28).

Conclusions:
Dual contraception utilization was less than one-third and having no child; receiving follow up counseling in the last 3 months; starting antiretroviral treatment; supporting to use were significantly associated with dual contraceptive utilization. It needs governmental and non-governmental organizations, other professionals and researchers involvement to improve dual contraceptive utilization.

Citation

Jifar MS, Handiso TB, Mare TD and Ibrahim SA. Dual Contraceptive Utilization and Associated Factors among Human Immunodeficiency Virus (HIV) Positive Women Attending Anti Retro Viral Therapy (ART) Clinic in Hossana Hospital, Southern Ethiopia. SM J Gynecol Obstet. 2017; 3(2): 1023.